Cognition Therapeutics, Inc.
NASDAQ:CGTX
0.4744 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -25.788 | -21.397 | -11.716 | -7.839 | -4.842 |
| Depreciation & Amortization
| 0.252 | 0.235 | 0.093 | 0.098 | 0.081 |
| Deferred Income Tax
| -2.44 | -6.54 | -0.416 | -0.07 | 0.238 |
| Stock Based Compensation
| 0.004 | 0.004 | 0.005 | 0 | 0 |
| Change In Working Capital
| 4.846 | -0.943 | 2.842 | 3.067 | 0.57 |
| Accounts Receivables
| 2.391 | -1.406 | -1.114 | 3.001 | -1.118 |
| Inventory
| -2.44 | 1.406 | 1.114 | -3.001 | 1.118 |
| Accounts Payables
| 2.44 | -1.092 | 2.165 | -0.364 | 0.862 |
| Other Working Capital
| 2.455 | 0.149 | 0.677 | 3.431 | -0.292 |
| Other Non Cash Items
| 2.758 | 6.54 | 0.383 | 0.836 | 0.494 |
| Operating Cash Flow
| -16.018 | -18.533 | -3.631 | -3.433 | -3.098 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.147 | -0.171 | -0.027 | -0.01 | -0.144 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.147 | -0.171 | -0.027 | 0 | 0 |
| Investing Cash Flow
| -0.147 | -0.171 | -0.027 | -0.01 | -0.144 |
| Financing Activities: | |||||
| Debt Repayment
| -0.811 | -1.396 | -0.268 | -0.004 | -0.05 |
| Common Stock Issued
| 5.332 | 5.324 | 44.217 | 0.047 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 5.014 | 1.618 | 9.252 | 5.722 | 2.844 |
| Financing Cash Flow
| 4.521 | 5.546 | 53.201 | 5.765 | 2.794 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0.004 | -0.001 | -0.011 | -0.023 | -0.06 |
| Net Change In Cash
| -11.64 | -13.159 | 49.532 | 2.299 | -0.508 |
| Cash At End Of Period
| 29.922 | 41.562 | 54.721 | 5.189 | 2.89 |